Contrast-enhanced MR imaging of the bladder and prostate.
The staging of both bladder and prostate carcinoma is important to determine appropriate therapy.  Routine clinical staging of these tumors, however, has only limited accuracy.  This article reviews the literature on contrast-enhanced MR of both bladder and prostate cancer, including technique optimization and potential benefits of contrast-enhanced studies.
Siegelman
E S
ES
Department of Radiology, Hospital of the University of Pennsylvania, Philadelphia, USA.
Schnall
M D
MD
D003287:Contrast Media; D005260:Female; D005682:Gadolinium; D006801:Humans; D008279:Magnetic Resonance Imaging / Q000379:methods*; D008297:Male; D011467:Prostate / Q000473:pathology*; D011469:Prostatic Diseases / Q000175:diagnosis*; D011471:Prostatic Neoplasms / Q000175:diagnosis*; D001743:Urinary Bladder / Q000473:pathology*; D001745:Urinary Bladder Diseases / Q000175:diagnosis*; D001749:Urinary Bladder Neoplasms / Q000175:diagnosis*
D003287:Contrast Media; D005682:Gadolinium